CLINICAL_TRIALS
trial_result
· 2016-06-27
Clinical Trial Update: A 4 Week Study With BI 144807 in Patients >= 50 Years With Wet Age Related Macular Degeneration [Phase 2]
Summary
A 4-week Phase 2 trial of BI 144807 in adults 50 and older with wet age-related macular degeneration completed, with results posted on 2016-06-27.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Wet Macular Degeneration | Phase 2 | Status: COMPLETED | Results posted: 2016-06-27